Literature DB >> 11845545

Pressor drugs in the treatment of cardiac arrest.

Norman A Paradis1, Volker Wenzel, John Southall.   

Abstract

The importance of vital organ perfusion in patients suffering cardiac arrest makes arterial vasomotor tone, and the resultant perfusion pressure, critical in resuscitation from sudden death. Although there are multiple mechanisms that may affect arterial vascular tone, historically, the therapy most commonly used has been catecholamine-induced adrenergic receptor stimulation, with catecholamine epinephrine being the commonest drug used. Over the last decade, however, it has become widely known that the utility of epinephrine during cardiopulmonary resuscitation is undefined. This has led to research into alternative agents, in particular nonadrenergic vasoactive peptides. Other agents appear promising. This article addresses pressor drugs and adrenergic agonists, including a review of their history, basic science, mechanism of action, and efficacy. Epinephrine is reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845545     DOI: 10.1016/s0733-8651(03)00065-1

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  9 in total

1.  Cardiopulmonary arrest and resuscitation disrupts cholinergic anti-inflammatory processes: a role for cholinergic α7 nicotinic receptors.

Authors:  Greg J Norman; John S Morris; Kate Karelina; Zachary M Weil; Ning Zhang; Yousef Al-Abed; Holly M Brothers; Gary L Wenk; Valentin A Pavlov; Kevin J Tracey; A Courtney Devries
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

2.  Cardiac arrest/cardiopulmonary resuscitation increases anxiety-like behavior and decreases social interaction.

Authors:  Gretchen N Neigh; Julia Kofler; Jessica L Meyers; Valerie Bergdall; Krista M D La Perle; Richard J Traystman; A Courtney DeVries
Journal:  J Cereb Blood Flow Metab       Date:  2004-04       Impact factor: 6.200

3.  Concept of the five 'A's for treating emergency arrhythmias.

Authors:  Hans-Joachim Trappe
Journal:  J Emerg Trauma Shock       Date:  2010-04

4.  Cardiac arrest and cardiopulmonary resuscitation dysregulates the hypothalamic-pituitary-adrenal axis.

Authors:  Gretchen N Neigh; Kate Karelina; Ning Zhang; Erica R Glasper; Michael J Owens; Paul M Plotsky; Charles B Nemeroff; A Courtney Devries
Journal:  J Cereb Blood Flow Metab       Date:  2009-06-24       Impact factor: 6.200

5.  Vasopressin improves outcome in out-of-hospital cardiopulmonary resuscitation of ventricular fibrillation and pulseless ventricular tachycardia: a observational cohort study.

Authors:  Stefek Grmec; Stefan Mally
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

6.  Effects of epinephrine and vasopressin on end-tidal carbon dioxide tension and mean arterial blood pressure in out-of-hospital cardiopulmonary resuscitation: an observational study.

Authors:  Stefan Mally; Alina Jelatancev; Stefek Grmec
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

7.  A treatment protocol including vasopressin and hydroxyethyl starch solution is associated with increased rate of return of spontaneous circulation in blunt trauma patients with pulseless electrical activity.

Authors:  Stefek Grmec; Matej Strnad; Darko Cander; Stefan Mally
Journal:  Int J Emerg Med       Date:  2008-11-12

Review 8.  Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?

Authors:  Volker Wenzel; Karl H Lindner
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

9.  Epinephrine plus chest compressions is superior to epinephrine alone in a hypoxia-induced porcine model of pseudo-pulseless electrical activity.

Authors:  Felipe Teran; Claire Centeno; Alexander L Lindqwister; William J Hunckler; William P Landis; Karen L Moodie; Frances S Shofer; Benjamin S Abella; Norman A Paradis
Journal:  Resusc Plus       Date:  2021-04-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.